01 3Pierre Fabre Dermo-Cosmetique
02 3Pierre Fabre Medicament
03 1Pierre Fabre Pharmaceuticals, Inc.
01 1No Action Indicated
02 6Voluntary Action Indicated
01 12019-09-20
02 12018-07-13
03 12016-04-15
04 12015-12-30
05 22015-01-16
06 12013-03-14
01 3Avene
02 3Gaillac
03 1Parsippany
01 6France
02 1U.S.A
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-09-20
City : Avene
State :
Country/Area : France
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-09-20
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-07-13
City : Gaillac
State :
Country/Area : France
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-07-13
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-04-15
City : Gaillac
State :
Country/Area : France
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-04-15
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-12-30
City : Parsippany
State : NJ
Country/Area : U.S.A
Zip : 07054-4409
District : NWJ
Center : CDER
Project Area : Postmarket Surv. and Epidemiolog...
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-12-30
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-01-16
City : Avene
State :
Country/Area : France
Zip :
District : ORA
Center : CFSAN
Project Area : Colors and Cosmetics Technology
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-01-16
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-01-16
City : Avene
State :
Country/Area : France
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-01-16
District Decision : No Action Indicated
Inspection End Date : 2013-03-14
City : Gaillac
State :
Country/Area : France
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2013-03-14
Pierre Fabre is a supplier offers 15 products (APIs, Excipients or Intermediates).
Find a price of Vinorelbine Tartrate bulk with DMF, CEP, JDMF offered by Pierre Fabre
Find a price of Milnacipran Hydrochloride bulk with DMF, JDMF offered by Pierre Fabre
Find a price of Chondroitin Sulfate Sodium bulk with CEP offered by Pierre Fabre
Find a price of Ciclopirox bulk offered by Pierre Fabre
Find a price of HYDROXYPROPYLMETHYLCELLULOSE bulk with CEP offered by Pierre Fabre
Find a price of Levomilnacipran bulk with DMF offered by Pierre Fabre
Find a price of Vinflunine Ditartrate bulk with DMF offered by Pierre Fabre
Find a price of Mucoproteose bulk with CEP offered by Pierre Fabre
Find a price of Ciclopirox Olamine bulk offered by Pierre Fabre
Find a price of HYDROXYPROPYLMETHYLCELLULOSE bulk offered by Pierre Fabre
Find a price of Idazoxan bulk offered by Pierre Fabre
Find a price of Milnacipran Hydrochloride bulk offered by Pierre Fabre
Find a price of Vinflunine Ditartrate bulk offered by Pierre Fabre
Find a price of Vinorelbine Tartrate bulk offered by Pierre Fabre
Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN GAILLAC, FRANCE. bulk offered by Pierre Fabre
